Clinical Trial Update: Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of Urelumab and Cetuximab in patients with advanced/metastatic colorectal cancer or advanced/metastatic head a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Urelumab (urelumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Colorectal Cancer, Head and Neck Cancer | Phase 1 | Status: COMPLETED